Chenglong Cheng
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Corrigendum to "Epigenetic modification and exosome 1 effects on autophagy in osteoarthritis" [Biochem. Pharmacol. 218 (2023) 115930].
Journal: Biochemical pharmacology
Published: June 16, 2024
Cuiru Keli Improves Postpartum Hypogalactia in Rats Through Secreted Frizzled-Related Protein 2-Wnt/β-catenin Signaling Pathway
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: November 14, 2023
Epigenetic modification and exosome effects on autophagy in osteoarthritis.
Journal: Biochemical pharmacology
Published: September 27, 2023
Progress in epigenetic regulation of milk synthesis, with particular emphasis on mRNA regulation and DNA methylation.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 06, 2023
M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.
Journal: Arthritis research & therapy
Published: March 16, 2023
Dysregulation of circRNAs in rheumatoid arthritis, with special emphasis on circRNAs secreted by exosomes and the crosstalk between circRNAs and RNA methylations.
Journal: International immunopharmacology
Published: March 10, 2023
CircRNA-mediated ceRNA mechanism in Osteoarthritis: Special emphasis on circRNAs in exosomes and the crosstalk of circRNAs and RNA methylation.
Journal: Biochemical pharmacology
Published: March 09, 2023
RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy.
Journal: Cell & bioscience
Published: March 04, 2023
Gandouling inhibits hepatic fibrosis in Wilson's disease through Wnt-1/β-catenin signaling pathway.
Journal: Journal of ethnopharmacology
Published: February 19, 2023
CircRnas in atherosclerosis, with special emphasis on the spongy effect of circRnas on miRnas.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 14, 2022
Huangqin Qingre Qubi Capsule inhibits RA pathology by binding FZD8 and further inhibiting the activity of Wnt/β-catenin signaling pathway.
Journal: Journal of ethnopharmacology
Published: September 07, 2022
Clematichinenoside AR inhibits the pathology of rheumatoid arthritis by blocking the circPTN/miR-145-5p/FZD4 signal axis.
Journal: International immunopharmacology
Published: August 18, 2022
Last Updated: 09/26/2026